Cervical cancer screening for transgender men in France
Gynecology Beyond Gender: Exploration and Identification of Potential Obstacles and Levers in France for Cervical Cancer Screening in Transgender Men, by Conducting an Opinion Survey in a Specific Population
This study looks at how well cervical cancer screening works for transgender men in France and aims to find ways to make it easier for them to access these important health services.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 25 Years to 65 Years |
| Sex | Female |
| Sponsor | Centre Hospitalier Universitaire de Nīmes Academic / other |
| Locations | 1 site (Nîmes) |
| Trial ID | NCT05924217 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on cervical cancer screening for transgender men in France, who are often excluded from organized health care programs despite being eligible for screening. The study aims to assess the accessibility and effectiveness of the national cervical cancer screening program for this population, addressing the barriers they face, such as discrimination and lack of awareness among health professionals. Participants will complete a survey questionnaire to gather data on their experiences and access to care. The goal is to improve health services for transgender individuals and reduce inequalities in cervical cancer screening.
Who should consider this trial
Good fit: Ideal candidates for this study are transgender men aged 25 to 65 who have retained their cervix and have a history of sexual activity.
Not a fit: Patients who are under 25 or over 65, do not have a cervix, or have a history of cervical cancer lesions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance access to cervical cancer screening for transgender men, leading to earlier detection and better health outcomes.
How similar studies have performed: While there is limited research specifically targeting cervical cancer screening in transgender men, studies addressing health care access for transgender individuals have shown promising results in improving health outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * transgender male (assigned female at birth but identifying as male) * aged 25 to 65 years * Having retained her cervix * Having had sex before. Exclusion Criteria: * Under 25 and over 65 * Not having retained his cervix * History of cancerous lesion of the cervix
Where this trial is running
Nîmes
- CHU de Nîmes — Nîmes, France (Recruiting)
Study contacts
- Principal investigator: ingrid JULIER — Centre Hospitalier Universitaire de Nīmes
- Study coordinator: ingrid JULIER
- Email: ingrid.julier@chu-nimes.fr
- Phone: 04.66.68.33.21
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.